Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ZYNE

Zynerba Pharmaceuticals (ZYNE)

Zynerba Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZYNE
DateTimeSourceHeadlineSymbolCompany
02/08/20246:22PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/19/20233:48PMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/202311:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20239:17AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20239:12AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20239:05AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20239:02AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20238:27AMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20238:27AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20238:24AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20238:22AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20238:22AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20238:22AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20238:22AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20238:21AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20238:20AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20238:19AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20238:19AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20237:56AMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20237:31AMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20237:17AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/11/20237:00AMPR Newswire (US)HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINENASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/04/20234:29PMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
10/04/20233:05PMGlobeNewswire Inc.Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and InstructionsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
09/29/20238:00AMGlobeNewswire Inc.Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023NASDAQ:ZYNEZynerba Pharmaceuticals Inc
09/27/20237:25AMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
09/27/20237:12AMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
09/27/20237:00AMPR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.NASDAQ:ZYNEZynerba Pharmaceuticals Inc
09/15/20237:00AMEdgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
09/14/20233:59PMEdgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ZYNE